Formulation and Characterization of a Dry Powder Inhaler Containing an ACE2 Miniprotein for SARS-CoV-2 Infection Inhibition
Glieca S, Montanini B, Cavazzini D, Levati E, Bolchi A, Garrapa V, Ottonello S, Bettini R, Buttini F.
Respiratory Drug Delivery 2022. Volume , 2022: 461-466.
I have a subscription
Log in for instant access.
I do not have a subscription
Purchase Article (in PDF format)
